Jazz Pharmaceuticals Ownership & Insider Activity

Jazz Pharmaceuticals (JAZZ) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 5.8% of shares outstanding. Institutional investors hold 79.0%. Over the past 90 days, insiders made 5 sales worth $15.5M.

Shares Outstanding

62.739M

Shares Float

54.511M

Insider Shares Owned

3.629M

Insider % Owned

5.8%

Institutional Shares Held

51.267M

Institutional % Held

79.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$15.5M total

Net Activity

Net Selling

Net Value (90d)

-$15.5M

Jazz Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 27, 2026	Robert Iannone	EVP, GLOBAL HEAD R&D & CMO	SELL	19.421K	$187.77	$12.0M
Aug 3, 2026	Bruce C Cozadd	DIRECTOR	SELL	6.000K	$252.98	$1.5M
Jul 1, 2026	Bruce C Cozadd	DIRECTOR	SELL	6.000K	$240.47	$1.4M
Jun 15, 2026	Mark D. Smith	DIRECTOR	SELL	1.157K	$230.55	$267K
Jun 10, 2026	Neena M Patil	EVP & CHIEF LEGAL OFFICER	SELL	1.200K	$231.83	$278K
Jun 1, 2026	Bruce C Cozadd	DIRECTOR	SELL	6.000K	$235.12	$1.4M
May 28, 2026	Neena M Patil	EVP & CHIEF LEGAL OFFICER	SELL	1.192K	$236.97	$282K
May 28, 2026	Samantha Pearce	EVP, CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$172.43	$870K
May 22, 2026	Rick E Winningham	DIRECTOR	SELL-OPTIONS	674.000	$189.82	$191K
May 22, 2026	Heather Ann McSharry	DIRECTOR	SELL	2.000K	$241.00	$482K
May 1, 2026	Bruce C Cozadd	DIRECTOR	SELL	6.000K	$203.33	$1.2M
Apr 1, 2026	Bruce C Cozadd	DIRECTOR	SELL	6.000K	$190.50	$1.1M
Mar 5, 2026	Patricia Carr	SVP, CHIEF ACCOUNTING OFFICER	SELL	2.723K	$184.96	$504K
Mar 3, 2026	Bruce C Cozadd	DIRECTOR	SELL	6.000K	$186.44	$1.1M

Date	Member	Party	Chamber	Action	Amount
Jul 12, 2023	Daniel Goldman	D	House	S	$15,001 - $50,000